Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
06/25/2009 | WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
06/25/2009 | WO2009049961A3 New no-donor aspirin derivatives |
06/25/2009 | WO2009017239A3 Process for producing toluidine compound |
06/25/2009 | US20090163720 Condensing an enone with an alkylthioenamine, cyclizing in the presence of ammonia to form e.g. 5-(1-Methylthio)ethyl-2-(trifluoromethyl)pyridine high yield; intermediates for novel insecticides |
06/25/2009 | US20090163558 Substituted Methyl Aryl or Heteroaryl Amide Compounds |
06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
06/25/2009 | US20090163498 Aryl Sulfonamides |
06/25/2009 | US20090163496 Antibacterial agents |
06/25/2009 | US20090160326 Organic electroluminescence material and element using the same |
06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
06/25/2009 | CA2708118A1 Mineralocorticoid receptor modulators |
06/25/2009 | CA2707988A1 Novel pyrazole-substituted arylamides |
06/24/2009 | EP2072501A1 Aminobenzamide derivatives as useful agents for controlling animal parasites |
06/24/2009 | EP1781614B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
06/24/2009 | CN101466678A Substituted 3-cyanopyridines as protein kinase inhibitors |
06/24/2009 | CN101466677A Diaryl substituted alkanes |
06/24/2009 | CN101466676A Pyridyl amide T-type calcium channel antagonists |
06/24/2009 | CN101463004A Method for preparing isonicotinic acid by non-catalytic hydrolyzing isonicotinonitrile in near-critical water medium |
06/24/2009 | CN100505377C Organic light emitting devices having carrier blocking layers comprising metal complexes |
06/24/2009 | CN100503677C New catalysts for selective isocyanate dimerization |
06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
06/23/2009 | US7550491 Ionic liquids having [N(CF3)2]− anions |
06/23/2009 | US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide |
06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
06/23/2009 | US7550481 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
06/23/2009 | US7550476 Condensed polycyclic compounds |
06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
06/23/2009 | US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents |
06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
06/23/2009 | US7550457 Therapy of vascular system diseases |
06/23/2009 | US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
06/23/2009 | US7550246 Dissolving a pi complex of tetramethylcyclopentadienyl 2,2'-bipyridin-1,1'-diyl iridium hydride in a solvent; irrradiating with a laser beam to deprotonate and produce an acidicsolution; chemically-amplified photoresists; color filters for liquid rystal; photography/printing; solubility; efficiency |
06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
06/23/2009 | CA2245080C Process for the preparation of heteroarylcarboxylic amides and esters |
06/18/2009 | WO2009076142A2 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids |
06/18/2009 | WO2009075874A1 Gamma secretase modulators |
06/18/2009 | WO2009075112A1 Oxime ether derivative and bactericide for agricultural and horticultural use |
06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
06/18/2009 | WO2009074594A1 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
06/18/2009 | WO2009074593A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
06/18/2009 | WO2009074592A1 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
06/18/2009 | WO2009074591A1 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
06/18/2009 | WO2009073943A1 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (hica) |
06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
06/18/2009 | WO2009010296A3 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
06/18/2009 | WO2009010156A3 Substituted phenylpropoargyl compounds, methods for the production thereof, and use of same as herbicides and plant growth regulators |
06/18/2009 | US20090158019 Computer Program Code Size Partitioning System for Multiple Memory Multi-Processing Systems |
06/18/2009 | US20090156825 Fluorescent compounds that bind to histone deacetylase |
06/18/2009 | US20090156803 Condensed furan compounds |
06/18/2009 | US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
06/18/2009 | US20090156646 Pyridylphenol compound and use thereof |
06/18/2009 | US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
06/18/2009 | US20090156616 Therapeutic agents |
06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
06/18/2009 | US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
06/18/2009 | US20090155203 Thrombopoietin mimetics |
06/18/2009 | US20090153045 Platinum complex compound and organic electroluminescence device using the same |
06/18/2009 | US20090153039 Green electroluminescent compounds and organic electroluminescent device using the same |
06/18/2009 | CA2707494A1 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
06/18/2009 | CA2707492A1 Gamma secretase modulators |
06/18/2009 | CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
06/17/2009 | EP2070913A1 Ester derivatives as phosphodiesterase inhibitors |
06/17/2009 | EP2070908A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
06/17/2009 | EP2069345A2 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
06/17/2009 | EP2069304A1 Improved electrochemical reduction of halogenated 4-aminopicolinic acids |
06/17/2009 | EP2069303A2 Antiviral protease inhibitors |
06/17/2009 | EP2069302A1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
06/17/2009 | EP2069291A1 Hdac inhibitors |
06/17/2009 | EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
06/17/2009 | EP2069287A1 Insecticidal compounds |
06/17/2009 | EP2069286A1 Inhibitors for glyt-1 |
06/17/2009 | EP1789410B1 Methylene dipiperidine derivatives |
06/17/2009 | EP1735345B1 Processes for preparing eptifibatide and pertinent intermediate compounds |
06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
06/17/2009 | EP1590341B1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
06/17/2009 | EP1565431B1 Cannabinoid receptor ligands |
06/17/2009 | EP1383736B1 Peptide deformylase inhibitors |
06/17/2009 | CN101460463A Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
06/17/2009 | CN101456841A Amide derivative and medicine |
06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
06/17/2009 | CN100500655C Process for the separation of gaseous mixture products in chloro-pyridine compounds production |
06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
06/16/2009 | US7547782 Met kinase inhibitors |
06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
06/16/2009 | US7547716 Sulfonamide derivatives |
06/16/2009 | US7547714 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease |
06/16/2009 | US7547713 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives |
06/16/2009 | US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e |
06/16/2009 | US7547701 cathepsin S inhibitors; e.g. N-(1-cyanocyclopropyl)-3-phenylmethanesulfonyl-2-(2,2,2-trifluoro-1-phenylethylamino)-propionamide; autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, pain, or atherosclerosis |